IRIS
DAMIANI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.848
AS - Asia 6.902
EU - Europa 5.404
SA - Sud America 1.426
Continente sconosciuto - Info sul continente non disponibili 392
AF - Africa 152
OC - Oceania 5
Totale 33.129
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.445
SG - Singapore 3.088
CN - Cina 1.553
UA - Ucraina 1.543
BR - Brasile 1.102
DE - Germania 805
HK - Hong Kong 740
IT - Italia 651
FI - Finlandia 621
VN - Vietnam 456
RU - Federazione Russa 394
FR - Francia 378
SE - Svezia 337
IE - Irlanda 258
CA - Canada 217
GB - Regno Unito 173
IN - India 167
TR - Turchia 166
KR - Corea 158
BD - Bangladesh 116
AR - Argentina 93
IQ - Iraq 76
CO - Colombia 69
MX - Messico 49
EC - Ecuador 47
PK - Pakistan 45
ID - Indonesia 40
ZA - Sudafrica 39
JP - Giappone 37
PL - Polonia 35
UZ - Uzbekistan 31
NL - Olanda 30
SA - Arabia Saudita 30
VE - Venezuela 30
IR - Iran 29
ES - Italia 28
CZ - Repubblica Ceca 27
CL - Cile 26
MA - Marocco 26
PY - Paraguay 22
PH - Filippine 20
BE - Belgio 19
CR - Costa Rica 19
AT - Austria 18
JO - Giordania 17
TT - Trinidad e Tobago 17
HN - Honduras 16
IL - Israele 15
JM - Giamaica 15
MY - Malesia 15
AE - Emirati Arabi Uniti 13
EU - Europa 13
EG - Egitto 12
GT - Guatemala 12
KE - Kenya 12
KZ - Kazakistan 12
NI - Nicaragua 12
PE - Perù 12
UY - Uruguay 12
BO - Bolivia 11
PR - Porto Rico 11
TG - Togo 11
AZ - Azerbaigian 10
RO - Romania 10
SV - El Salvador 10
TN - Tunisia 10
CW - ???statistics.table.value.countryCode.CW??? 9
OM - Oman 9
AL - Albania 8
BG - Bulgaria 8
DZ - Algeria 8
LT - Lituania 8
RS - Serbia 8
BH - Bahrain 7
KG - Kirghizistan 7
GP - Guadalupe 6
HU - Ungheria 6
LB - Libano 6
SY - Repubblica araba siriana 6
CH - Svizzera 5
GE - Georgia 5
PS - Palestinian Territory 5
AU - Australia 4
ET - Etiopia 4
GR - Grecia 4
LV - Lettonia 4
NP - Nepal 4
PT - Portogallo 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
PA - Panama 3
RW - Ruanda 3
TH - Thailandia 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 32.704
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.115
Ann Arbor 1.689
Singapore 1.266
Ashburn 1.254
Fairfield 1.223
Houston 1.201
San Jose 1.134
Jacksonville 1.111
Beijing 841
Chandler 762
Hong Kong 732
Dearborn 590
Council Bluffs 523
Wilmington 506
Seattle 453
Cambridge 374
Boardman 321
Dublin 255
Princeton 255
Los Angeles 239
Lauterbourg 238
Dallas 192
Ho Chi Minh City 155
Seoul 146
Hefei 143
Buffalo 135
Santa Clara 121
Udine 114
Izmir 111
Munich 110
New York 108
São Paulo 105
San Diego 104
Helsinki 95
Hanoi 88
Ottawa 77
Trieste 66
The Dalles 64
Ogden 62
Norwalk 56
Orem 55
Toronto 46
Turku 46
Des Moines 45
Phoenix 45
Redondo Beach 45
Milan 42
Rio de Janeiro 41
Montreal 36
Tokyo 36
Nanjing 35
Mumbai 34
Baghdad 32
Warsaw 32
Chicago 29
Frankfurt am Main 29
Regensburg 29
Atlanta 28
Kunming 28
Tashkent 28
Rome 27
Pittsburgh 26
Belo Horizonte 25
Chennai 25
Dong Ket 25
Porto Alegre 25
Brooklyn 23
London 23
Brasília 22
Guangzhou 22
Bogotá 21
Boston 21
Denver 21
Stockholm 21
San Francisco 20
Augusta 19
Da Nang 19
Johannesburg 19
Poplar 19
Simi Valley 19
Washington 19
Brussels 18
Mexico City 18
Nuremberg 18
Philadelphia 18
Jinan 17
Quito 17
Amman 16
Andover 15
Columbus 15
Curitiba 15
Medellín 15
San José 15
Istanbul 14
Lahore 14
Leawood 14
Manchester 14
Nanchang 14
Asunción 13
Campinas 13
Totale 20.629
Salva come PNG Salva come JPEG
Nome #
Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy 288
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 231
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 231
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non MDR cells to different anthracycline derivatives 229
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 219
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 215
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 214
“Fibre nervose peptidergiche intraepidermiche: uno studio immunoistochimico”. 203
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 192
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 192
ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission 191
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 189
Histone post-translational modifications associated to BAALC expression in leukemic cells. 187
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia 186
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells 185
Multipotent Mesenchymal Stem Cells Can Be Isolated and Grown from Many Tissues (Bone Marrow, Liver and Heart) 185
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. 184
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 179
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome 178
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine 178
A study of the material in the ATLAS inner detector using secondary hadronic interactions 174
Clinical feature and outcome in seven patients wuth hyaline or mixed variant of Castleman’s disease. A single centre experience 173
A mutational status of IGVH genes consisten with antigen-driven selection has prognostic impact istead of percento f mutations in B-cell chronic lymphocytic leukemia 173
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML 172
5-AZACITIDINE FIVE DAYS/MONTHLY SCHEDULE IN SYMPTOMATIC LOW-RISK (IPSS: 0-1) MYELODISPLASTIC (MDS) PATIENTS. CLINICAL AND BIOLOGICAL EFFECTS Authors 171
Epstein-Barr virus (EBV) reactivation in a patient treated with ATG for severe aplastic anemia 168
Suggestive evidence for a Microanatomical Relationship betweeb Mast Cells and Nerve Fibres Containing Substance P, Calcitonin Gene Related Peptide, Vasoactive Intestinal Polypeptide, and Somatostatin in the rat Mesentery. 168
“Overexpression of multidrug resistance-associated P-170 glycoprotein in acute non lymphocytic leukemia”. 167
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 167
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia 165
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 164
Granulocyte-macrophage colony -stimulating factor in acute nonlymphocytic leukemia before and after chemo therapy”. 164
Autologous stem cell transplantation in chronic carriers of hepatitis B virus and hepatitis C virus affected by onco-hematologic diseases. 163
Autologus stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome. 162
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia 162
Acute promyelocytic leucemia: low expression of multidrug resistance phenotype at onset suggest a favourable effect of gentuzumab ozogamicyn (CMA-676 160
The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia. 160
Visualization of PGP 9.5 immunoreactive nerve terminals in the mouse snout epidermis. 160
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 160
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 160
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 158
Unexpected phenotype of a typical NPM1 mutant 158
A simple Prognostic Scoring System for newly diagnosed acute leukaemia patients with normal karyotype: a retrospective analysis on 173 cases. 156
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 154
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 154
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 years treated with induction regimens including fludarabine: retrospective analysis of 224 cases 153
ABCB1 (PGP) and ABCG (BCRP) proteins are independent prognostic factors for complete remissione and relapse risk, respectively in normal karyotype adult de novo acute myeloid leukemia. 152
Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression 152
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement 151
“Long Term Follow-up of the Italian Trial of Interferon-a Versus Conventional Chemotherapy in Chronic Myeloid Leukemia”. 150
KIR POLYMORPHISM IN REDUCED INTENSITY HLA-ID SIBLING STEM CELL TRANSPLANTATION: IMPACT ON CLINICAL OUTCOME 150
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias 150
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera. 150
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. 150
“Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas”. 149
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. 149
“Espressione dell’antigene CD34 nei tessuti normali e patologici e possibili applicazioni cliniche delle cellule CD34”. 148
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 148
Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia. 148
FEASIBILITY OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH CD34 SELECTED STEM CELLS: OUTCOME AND IMMUNOLOGICAL COMPLICATIONS 147
Castleman's disease: an unusual cause of mediastinal mass and anemia. 147
“D-Verapamil downmodulates P-170 associated resistance to doxorubicin, daunorubicin and idarubicin”. 147
KERATOCONJUNCTIVITIS TREATMENT WITH AUTOLOGOUS SERUM EYE IN PATIENTS WITH SEVERE CHRONIC GVHD 147
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients 146
“Case report: mdr-1 gene amplification in acute lymphoblastic leukemia prior to antileukemic treatment”. 146
Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy. 145
CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis”. 144
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation 143
Acute promyelocyttic leucemia: low expression of multidrug resistance phenotype at onset suggests a favorable effect of Gemtuzumab Ozogamycin (CMA 676) 143
A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of aurtologoaus stem cell transplantation in first remission on autcome 143
“CD34+ selected versus un-manipulated autologous stem cell transplantation in multiple myeoloma: impact on dendritic and immune recovery and on complications due to infections”. 142
Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma 142
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. 142
Flow cytometry evaluation of plasma cells contaminating leukapheresis pre- and post- CD34-positive selection- 141
“The use of G-CSF during first line chemotherapy adversely affects the yield of PBSC mobilization in non-Hodgkins’ Lymphoma patients” 141
Dendritic cell recovery after autologous stem cell transplantation 141
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance 141
Prognostic factors anad expression of multidrug-resistance related proteins in 36 patients with acute promyelocytic leukemia. 140
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 140
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 140
Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery 140
“Treatment of Ph+ chronic myeloid leukemia by gamma interferon”. 138
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults. 138
Serotoninergic fibres form dense synaptic contacts with Purkinje cells in the mouse cerebellar cortex--an immunohistochemical study 138
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias 137
“Multidrug resistance (MDR1) in acute myelogenous leukemia: is it time to test?” 137
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) in de novo adult acute lymphoblastica leukemia 137
Teaching students’ patient safety core competencies: results of an Italian program 137
Peripheral blood stem cell mobilization in multiple myeloma: advantage of 7 vs. 4 g/m2 cyclophosfamide on stem cell quality and plasma cell mobilization. 136
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 136
The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leucemia 136
Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells. 135
Sequential study of cytokine and lymphocyte patterns in patients with chronic agraft versus host disease after reduced intensity conditioning allogenic stem cell transplantation 135
Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia. 134
A SIMPLE PROGNOSTIC SCORING SYSTEM FOR NEWLY DIAGNOSED ACUTE LEUKAEMIA PATIENTS WITH NORMAL KARYOTYPE: A RETROSPECTIVE ANALYSIS ON 420 CASES 134
High dose therapy with stem cell rescue in elderly atients with aggressive poor risk lymphomas: a review of 14 cases. 132
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. 132
Successful treatment of hematological and extramedullary relapse of MLL-positive acute lymphoblastic leukemia after bone marrow transplantation using donor leukocyte infusion 132
Isolation, characterization and in vitro growth of human multipotent adult cardiac progenitor cells 132
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse 132
Totale 15.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.927
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.927
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.500 0 0 0 167 64 47 78 103 19 311 396 315
2022/20231.861 273 97 16 226 188 519 6 149 254 31 57 45
2023/2024600 98 58 35 27 71 84 10 33 86 44 13 41
2024/20254.435 87 346 209 117 140 187 262 285 476 247 867 1.212
2025/20268.227 704 779 644 733 1.087 695 1.119 280 614 808 417 347
2026/20272.391 183 507 748 953 0 0 0 0 0 0 0 0
Totale 33.129